Zynex Medical - ZYXI Net earnings per share for the last four quarters

Zynex, Inc. (ZYXI) bases the production of its rehabilitation and pain management equipment at its Colorado plant, leveraging the demand for drug alternatives. The expansion of the consumer segment and direct deliveries to hospitals mitigate insurance reimbursement risks. Meanwhile, market saturation for portable devices is forcing the business to venture into respiratory monitoring. Market price action on GURU.Markets shows that the EPS (TTM) is -1726.50.
Zynex Medical - analytical breakdowns and key metrics (ZYXI)

This indicator measures the rate of change in net earnings per share over the last twelve months, allowing for the determination of the actual business scaling speed relative to market expectations. By analyzing the annual EPS TTM growth rate, an investor assesses the diversification efficiency of Zynex, Inc. (ZYXI), where the implementation of patient monitoring systems is intended to reduce profit dependence on sales of a single primary electrotherapy device.